Archives for October 6, 2008

← 2008

Drug delivery: News in brief

By Nick Taylor

in-PharmaTechnologist.com’s latest round up of developments in drug delivery includes Critical Pharmaceuticals’ sustained release hGH, Phase III results for AP Pharma and nanodiamonds.

Marchesini to open doors at new Siena plant

By Gareth Macdonald

Ahead of the “open house” at its facility in Monteriggioni, Siena, Italian machining specialist Marchesini spoke with in-PharmaTechnologist.com about the new plant and its role in the firm's offering to the drug industry.

Alcan's buys new Indian plant

By Gareth Macdonald

Alcan says that its new Indian facility further strengthens its position “in pharmaceutical flexibles through growth in emerging markets,” which contributed about 20 per cent of its revenue last year.

Solid state chemistry rounds out Almac Sciences

By Phil Taylor

Almac Sciences of Northern Ireland has introduced a new business unit covering solid state chemistry in a move that addresses a missing link in its technology portfolio.

Lilly to acquire ImClone for $6.5bn

By Nick Taylor

Eli Lilly has agreed to acquire ImClone for $6.5bn and in doing so appears to have snatched the biotech away from Bristol-Myers Squibb (BMS), which first tabled a bid back in July.